UPDATE: Morgan Stanley Reiterates On Celgene Ahead Of Markman Hearing
May 12, 2014 at 09:07 AM EDT
In a report published Monday, Morgan Stanley analyst Matthew Harrison reiterated an Equal-Weight rating on Celgene (NASDAQ: CELG), but ...